GU Cancers 2020 | Frontline immunotherapy for bladder cancer

Name: Frontline immunotherapy for bladder cancer
Uploaded: 2020-02-15T23:40:08Z
Description: Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, tells us about first-line immunotherapy in metastatic urothelial carcinoma. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Elizabeth Plimack • 15 Feb 2020

GU Cancers 2020

Bladder Cancer Genitourinary Cancer Antibodies Checkpoint Inhibitors Enfortumab vedotin Erdafitinib Pembrolizumab

Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, tells us about first-line immunotherapy in metastatic urothelial carcinoma. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.